The Latest Breaking News from FDA

With abortion increasingly restricted in many states, Sen. Patty Murray (D-Wash.), hopes to persuade Republicans to back insurance coverage for over-the-counter birth control.

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Letters: In all the domestic abuse cases where the CPS took no further action, it had made the right decision, says chief inspector Andrew T Cayley, while Duncan Woodhead of the FDA union also rejects claims of ‘cherrypicking’

Gene therapy has helped doctors make major strides in treating inherited blindness, and it's now being explored for other conditions.